MedTrace Logo

A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy

NCT02111824 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2021-09-17

No results posted yet for this study

Summary

The goal of this clinical research study is to test the use of a minimally invasive multimodality image-guided (MIMIG) intervention system used for performing a lung biopsy. The safety of the MIMIG intervention system will also be studied.

Conditions

  • Lung Neoplasms
  • Thoracic Neoplasms
  • Neoplasms by Site
  • Neoplasms
  • Lung Diseases

Interventions

DEVICE

MIMIG System

Minimally Invasive MultiModality Imaging Guidance System (MIMIG)

DRUG

Indocyanine Green (ICG)

Use of ICG as staining for fiberoptic visualization of lung tissue via introducer needle prior to obtaining tissue samples.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • The Methodist Hospital Research Institute

    lead OTHER

Principal Investigators

  • Alda Tam, MD · MD Anderson Cancer Center Interventional Radiology

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-05
Primary Completion
2019-11-30
Completion
2019-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02111824 on ClinicalTrials.gov